Clinical Trial Update: Personalized Circulating DNA Follow-up in Melanoma (PERCIMEL) [NA]

View source ↗

Summary

The PERCIMEL clinical trial investigates personalized circulating DNA follow-up in melanoma and is listed as active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Institut de Cancérologie de Lorraine | Conditions: Melanoma | NA | Status: ACTIVE_NOT_RECRUITING